GTJA: The new paradigm reshapes the drug development landscape, and the cycle of inventory reduction for Active Pharmaceutical Ingredient is approaching its end.

The CXO adjustments are nearing completion, and the Industry is moving towards the development stage 2.0; the API destocking cycle is coming to an end, seizing opportunities for industrial transformation.

Zhitong FinanceFeb 14 02:47 ET

China's Healthcare Sector Could Ride the AI Wave -- Market Talk

WSJFeb 14 02:13 ET

Trending Industry Today: WUXI BIO Leads Gains In Biotechnology Stocks

Moomoo NewsFeb 14 00:10 ET

Trending Industry Today: TIGERMED Leads Gains In CRO Stocks

Moomoo NewsFeb 14 00:00 ET

Hong Kong stocks fluctuated | CRO Concept stocks continued to surge in the morning, WUXI BIO (02269) and TIGERMED (03347) both rose over 9%.

In the early session, CRO Concept stocks continued to rise. As of the time of writing, WUXI BIO (02269) is up 9.59%, priced at 22.85 HKD; TIGERMED (03347) is up 9.09%, priced at 31.2 HKD; GENSCRIPT BIO (01548) is up 7.22%, priced at 11.88 HKD.

Zhitong FinanceFeb 13 22:11 ET

Express News | Hong Kong indexes extend gains on Friday, auto makers rise on broad integration of DeepSeek. Biopharma shares soar.

Moomoo 24/7Feb 13 21:31 ET